Vascular adhesion protein 1 mediates binding of immunotherapeutic effector cells to tumor endothelium

Journal of Immunology

Volumn 166, Issue 11, 2001, Pages 6937-6943

  Irjala, Heikki ^a   Salmi, Marko ^a   Alanen, Kalle ^b   Grénman, Reidar ^b   Jalkanen, Sirpa ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULAR ADHESION PROTEIN 1;

ARTICLE; CANCER IMMUNOTHERAPY; CANCER TISSUE; CELL INTERACTION; CONTROLLED STUDY; CORRELATION FUNCTION; EFFECTOR CELL; ENDOTHELIUM; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LYMPHOKINE ACTIVATED KILLER CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; TUMOR ASSOCIATED LEUKOCYTE;

EID: 0035336167     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.11.6937     Document Type: Article

References (37)

1. Vokes, E. E., R. R. Weichselbaum, S. M. Lippman, and W. K. Hong. 1993. Head and neck cancer. N. Engl. J. Med. 328:184.
2. Rosenberg, S. A., J. R. Yannelli, J. C. Yang, S. L. Topalian, D. J. Schwartzentruber, J. S. Weber, D. R. Parkinson, C. A. Seipp, J. H. Einhorn, and D. E. White. 1994. Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2. J. Natl. Cancer Inst. 86:1159.
3. Butcher, E. C. 1991. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 67:1033.
4. Springer, T. A. 1994. Traflic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76:301.
5. Carlos, T. M., and J. M. Harlan. 1994. Leukocyte-endothelial adhesion molecules. Blood 84:2068.
6. Salmi, M., and S. Jalkanen. 1992. A 90-kilodalton endothelial cell molecule mediating lymphocyte binding in humans. Science 257:1407.
7. Salmi, M., S. Tohka, E. L. Berg, E. C. Butcher, and S. Jalkanen. 1997. Vascular adhesion protein 1 (VAP-1) mediates lymphocyte subtype-specific, selectin-independent recognition of vascular endothelium in human lymph nodes. J. Exp. Med. 186:589.
8. Salmi, M., R. Grenman, S. Grenman, E. Nordman, and S. Jalkanen. 1995. Tumor endothelium selectively supports binding of IL-2-propagated tumor-infiltrating lymphocytes. J. Immunol. 154:6002.
9. Yoong, K. F., G. McNab, S. G. Hubscher, and D. H. Adams. 1998. Vascular adhesion protein-1 and ICAM-1 support the adhesion of tumor-infiltrating lymphocytes to tumor endothelium in human hepatocellular carcinoma. J. Immunol. 160:3978.
10. Kurkijarvi, R., D. H. Adams, R. Leino, T. Mottonen, S. Jalkanen, and M. Salmi. 1998. Circulating form of human vascular adhesion protein-1 (VAP-1): increased serum levels in inflammatory liver diseases. J. Immunol. 161:1549.
11. Arvilommi, A. M., M. Salmi, K. Kalimo, and S. Jalkanen. 1996. Lymphocyte binding to vascular endothelium in inflamed skin revisited: a central role for vascular adhesion protein-1 (VAP-1) Eur. J. Immunol. 26:825.
12. Streeter, P. R., B. T. Rouse, and E. C. Butcher. 1988. Immunohistologic and functional characterization of a vascular addressin involved in lymphocyte homing into peripheral lymph nodes. J. Cell Biol. 107:1853.
13. Jutila, M. A., R. F. Bargatze, S. Kurk, R. A. Warnock, N. Ehsani, S. R. Watson, and B. Walcheck. 1994. Cell surface P- and E-selectin support shear-dependent rolling of bovine γ/δ T cells. J. Immunol. 153:3917.
14. Briskin, M., D. Winsor-Hines, A. Shyjan, N. Cochran, S. Bloom, J. Wilson, L. M. McEvoy, E. C. Butcher, N. Kassam, C. R. Mackay, W. Newman, and D. J. Ringler. 1997. Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue. Am. J. Pathol. 151:97.
15. Airas, L., M. Salmi, and S. Jalkanen. 1993. Lymphocyte-vascular adhesion protein-2 is a novel 70-kDa molecule involved in lymphocyte adhesion to vascular endothelium. J. Immunol. 151:4228.
16. Wellicome, S. M., M. H. Thornhill, C. Pitzalis, D. S. Thomas, J. S. Lanchbury, G. S. Panayi, and D. O. Haskard. 1990. A monoclonal antibody that detects a novel antigen on endothelial cells that is induced by tumor necrosis factor, IL-1, or lipopolysaccharide. J. Immunol. 144:2558.
17. Wellicome, S. M., P. Kapahi, J. C. Mason, Y. Lebranchu, H. Yarwood, and D. O. Haskard. 1993. Detection of a circulating form of vascular cell adhesion molecule-1: raised levels in rheumatoid arthritis and systemic lupus erythematosus. Clin. Exp. Immunol. 92:412.
18. Jalkanen, S. T., and E. C. Butcher. 1985. In vitro analysis of the homing properties of human lymphocytes: developmental regulation of functional receptors for high endothelial venules. Blood 66:577.
19. Picker, L. J., and E. C. Butcher. 1992. Physiological and molecular mechanisms of lymphocyte homing. Annu. Rev. Immunol. 10:561.
20. Salmi, M., and S. Jalkanen. 1997. How do lymphocytes know where to go: current concepts and enigmas of lymphocyte homing. Adv. Immunol. 64:139.
21. Zocchi, M. R., and A. Poggi. 1993. Lymphocyte-endothelial cell adhesion molecules at the primary tumor site in human lung and renal cell carcinomas. J. Natl. Cancer Inst. 85:246.
22. Fox, S. B., G. D. Turner, K. C. Gatter, and A. L. Harris. 1995. The increased expression of adhesion molecules ICAM-3, E- and P- selectins on breast cancer endothelium. J. Pathol. 177:369.
23. Onrust, S. V., P. M. Hartl, S. D. Rosen, and D. Hanahan. 1996. Modulation of L-selectin ligand expression during an immune response accompanying tumorigenesis in transgenic mice. J. Clin. Invest. 97:54.
24. Melder, R. J., G. C. Koenig, B. P. Witwer, N. Safabakhsh, L. L. Munn, and R. K. Jain. 1996. During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium. Nat. Med. 2:992.
25. Arvilommi, A. M., M. Salmi, and S. Jalkanen. 1997. Organ-selective regulation of vascular adhesion protein-1 expression in man. Eur. J. Immunol. 27:1794.
26. Fukumura, D., H. A. Salehi, B. Witwer, R. F. Tuma, R. J. Melder, and R. K. Jain. 1995. Tumor necrosis factor α-induced leukocyte adhesion in normal and tumor vessels: effect of tumor type, transplantation site, and host strain. Cancer Res. 55:4824.
27. Ogawa, M., T. Tsutsui, J. P. Zou, J. Mu, R. Wijesuriya, W. G. Yu, S. Herrmann, T. Kubo, H. Fujiwara, and T. Hamaoka. 1997. Enhanced induction of very late antigen 4/lymphocyte function-associated antigen 1-dependent T-cell migration to tumor sites following administration of interleukin 12. Cancer Res. 57:2216.
28. 2 integrin in lymphotoxin-mediated leukocyte recruitment in tumor microvessels. J. Clin. Invest. 99:2246.
29. Butcher, E. C., R. G. Scollay, and I. L. Weissman. 1980. Organ specificity of lymphocyte migration: mediation by highly selective lymphocyte interaction with organ-specific determinants on high endothelial venules. Eur. J. Immunol. 10: 556.
30. Stamper, H. B., Jr., and J. I. Woodruff. 1976. Lymphocyte homing into lymph nodes: in vitro demonstration of the selective affinity of recirculating lymphocytes for high-endothelial venules. J. Exp. Med. 144:828.
31. Stevens, S. K., I. L. Weissman, and E. C. Butcher. 1982. Differences in the migration of B and T lymphocytes: organ-selective localization in vivo and the role of lymphocyte-endothelial cell recognition. J. Immunol. 128:844.
32. Salmi, M., K. Granfors, M. Leirisalo-Repo, M. Hamalainen, R. MacDermott, R. Leino, T. Havia, and S. Jalkanen. 1992. Selective endothelial binding of interleukin-2-dependent human T-cell lines derived from different tissues. Proc. Natl. Acad. Sci. USA 89:11436.
33. Pankonin, G., B. Reipert, and A. Ager. 1992. Interactions between interleukin-2-activated lymphocytes and vascular endothelium: binding to and migration across specialized and non- specialized endothelia. Immunology 77:51.
34. Pockaj, B. A., R. M. Sherry, J. P. Wei, J. R. Yannelli, C. S. Carter, S. F. Leitman, J. A. Carasquillo, S. M. Steinberg, S. A. Rosenberg, and J. C. Yang. 1994. Localization of 111-indium-labeled tumor infiltrating lymphocytes to tumor in patients receiving adoptive immunotherapy: augmentation with cyclophosphamide and correlation with response. Cancer 73:1731.
35. Merrouche, Y., S. Negrier, C. Bain, V. Combaret, A. Mercatello, B. Coronel, J. F. Moskovtchenko, P. Tolstoshev, R. Moen, T. Philip, and M.C. Favrot. 1995. Clinical application of retroviral gene transfer in oncology: results of a French study with tumor-infiltrating lymphocytes transduced with the gene of resistance to neomycin. J. Clin. Oncol. 13:410.
36. Fisher, B., B. S. Packard, E. J. Read, J. A. Carrasquillo, C. S. Carter, S. L. Topalian, J. C. Yang, P. Yolles, S. M. Larson, and S. A. Rosenberg. 1989. Tumor localization of adoptively transferred indium-111 labeled tumor infiltrating lymphocytes in patients with metastatic melanoma. J. Clin. Oncol. 7:250.
37. Sasaki, A., R. J. Melder, T. L. Whiteside, R. B. Herberman, and R. K. Jain. 1991. Preferential localization of human adherent lymphokine-activated killer cells in tumor microcirculation. J. Natl. Cancer Inst. 83:433.